Succinylcholine is a paralytic drug used to induce muscle relaxation and short-term paralysis, usually to facilitate tracheal intubation. The two manufacturers are now able to manufacture enough succinylcholine to meet market demands.
This is a positive development for patients and physicians, considering an April 2011 ASA survey on drug shortages found that 47.6 percent of respondents were experiencing a shortage of succinylcholine.
Read the ASA release on succinylcholine.
Related Articles on Anesthesia:
Anesthesiologist Dr. Marshall Joins Joins North Dakota’s Medcenter One
Florida Anesthesiologists Launch National Consulting Firm
Pennsylvania Anesthesiologist Pleads Guilty to Tax Case in Federal Court
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.